abstract |
The present invention relates to an anticancer agent comprising a TMPRSS4 (transmembrane protease, serine 4) inhibitor as an active ingredient, and more particularly, to an anticancer agent comprising an inhibitor that inhibits the activity of TMPRSS4 as an active ingredient. The anticancer agent of the present invention can be effectively used for anticancer treatment by effectively inhibiting the expression of TMPRSS4 in cancer cells, thereby inhibiting the mobility and growth of cancer cells. |